Certain risk factors can make you more prone to developing a B12 deficiency
Rivfloza was okayed for children nine years and older to treat a rare genetic condition that affects the kidneys, known as primary hyperoxaluria type 1 (PH1).View Our Interactive Dashboard on Oligonucleotide Therapies (Free Excel Available) Ionis tees up NDAs for rare disease treatments after two late-stage trial winsThe industry is looking for cures to a wide spectrum of diseases like cancer (such as melanoma, pancreatic, liver, glioblastoma, breast and ovarian cancer), cystic fibrosis, Alzheimers disease, Parkinsons disease, hepatitis B, asthma, Rett syndrome, non-alcoholic steatohepatitis, and IgA nephropathy through its research on ONTs.In January, Ionis announced late-stage results wherein its RNA-targeted hereditary angioedema (HAE) candidate, donidalorsen, significantly reduced the rate of HAE attacks in patients treated every four weeks and patients treated every eight weeks
Certain chronic illnesses, such as hepatitis and HIV, automatically disqualify someone from donating
Do not administer BYETTA after a meal
Promotional language used to identify the product and its category - including phrases such as "supporting your blood pressure naturally," "premium ingredients," and "best option for supporting your blood pressure" - originates with the Vital Blood brand's own published marketing materials and is identified in this article for reader-context purposes, not as independent endorsement or performance guarantee
